Click for best price
GABA Receptor Agonist Drug Market Size, Share 2022
This report contains market size and forecasts of GABA Receptor Agonist Drug in global, including the following market information:
Global GABA Receptor Agonist Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global GABA Receptor Agonist Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five GABA Receptor Agonist Drug companies in 2021 (%)
The global GABA Receptor Agonist Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bamaluzole Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GABA Receptor Agonist Drug include Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline and NovaDel Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the GABA Receptor Agonist Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GABA Receptor Agonist Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global GABA Receptor Agonist Drug Market Segment Percentages, by Type, 2021 (%)
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
Global GABA Receptor Agonist Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global GABA Receptor Agonist Drug Market Segment Percentages, by Application, 2021 (%)
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
Global GABA Receptor Agonist Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global GABA Receptor Agonist Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GABA Receptor Agonist Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies GABA Receptor Agonist Drug revenues share in global market, 2021 (%)
Key companies GABA Receptor Agonist Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies GABA Receptor Agonist Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort
| Report Attributes |
Report Details |
| Report Title |
GABA Receptor Agonist Drug Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 GABA Receptor Agonist Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GABA Receptor Agonist Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GABA Receptor Agonist Drug Overall Market Size
2.1 Global GABA Receptor Agonist Drug Market Size: 2021 VS 2028
2.2 Global GABA Receptor Agonist Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global GABA Receptor Agonist Drug Sales: 2017-2028
3 Company Landscape
3.1 Top GABA Receptor Agonist Drug Players in Global Market
3.2 Top Global GABA Receptor Agonist Drug Companies Ranked by Revenue
3.3 Global GABA Receptor Agonist Drug Revenue by Companies
3.4 Global GABA Receptor Agonist Drug Sales by Companies
3.5 Global GABA Receptor Agonist Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 GABA Receptor Agonist Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers GABA Receptor Agonist Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 GABA Receptor Agonist Drug Players in Global Market
3.8.1 List of Global Tier 1 GABA Receptor Agonist Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 GABA Receptor Agonist Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global GABA Receptor Agonist Drug Market Size Markets, 2021 & 2028
4.1.2 Bamaluzole
4.1.3 Phenibut
4.1.4 Baclofen
4.1.5 Gaboxadol
4.1.6 Klonopin (clonazepam)
4.1.7 Tiagbine
4.2 By Type - Global GABA Receptor Agonist Drug Revenue & Forecasts
4.2.1 By Type - Global GABA Receptor Agonist Drug Revenue, 2017-2022
4.2.2 By Type - Global GABA Receptor Agonist Drug Revenue, 2023-2028
4.2.3 By Type - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
4.3 By Type - Global GABA Receptor Agonist Drug Sales & Forecasts
4.3.1 By Type - Global GABA Receptor Agonist Drug Sales, 2017-2022
4.3.2 By Type - Global GABA Receptor Agonist Drug Sales, 2023-2028
4.3.3 By Type - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
4.4 By Type - Global GABA Receptor Agonist Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global GABA Receptor Agonist Drug Market Size, 2021 & 2028
5.1.2 Attention Deficit Hyperactivity Disorder (ADHD)
5.1.3 Psychiatric Disorders and Depression
5.1.4 Alzheimer
5.1.5 Epilepsy and Seizure
5.1.6 Anxiety and Sleep Disorders
5.1.7 Obesity and Alcoholism
5.2 By Application - Global GABA Receptor Agonist Drug Revenue & Forecasts
5.2.1 By Application - Global GABA Receptor Agonist Drug Revenue, 2017-2022
5.2.2 By Application - Global GABA Receptor Agonist Drug Revenue, 2023-2028
5.2.3 By Application - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
5.3 By Application - Global GABA Receptor Agonist Drug Sales & Forecasts
5.3.1 By Application - Global GABA Receptor Agonist Drug Sales, 2017-2022
5.3.2 By Application - Global GABA Receptor Agonist Drug Sales, 2023-2028
5.3.3 By Application - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
5.4 By Application - Global GABA Receptor Agonist Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global GABA Receptor Agonist Drug Market Size, 2021 & 2028
6.2 By Region - Global GABA Receptor Agonist Drug Revenue & Forecasts
6.2.1 By Region - Global GABA Receptor Agonist Drug Revenue, 2017-2022
6.2.2 By Region - Global GABA Receptor Agonist Drug Revenue, 2023-2028
6.2.3 By Region - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
6.3 By Region - Global GABA Receptor Agonist Drug Sales & Forecasts
6.3.1 By Region - Global GABA Receptor Agonist Drug Sales, 2017-2022
6.3.2 By Region - Global GABA Receptor Agonist Drug Sales, 2023-2028
6.3.3 By Region - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America GABA Receptor Agonist Drug Revenue, 2017-2028
6.4.2 By Country - North America GABA Receptor Agonist Drug Sales, 2017-2028
6.4.3 US GABA Receptor Agonist Drug Market Size, 2017-2028
6.4.4 Canada GABA Receptor Agonist Drug Market Size, 2017-2028
6.4.5 Mexico GABA Receptor Agonist Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe GABA Receptor Agonist Drug Revenue, 2017-2028
6.5.2 By Country - Europe GABA Receptor Agonist Drug Sales, 2017-2028
6.5.3 Germany GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.4 France GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.5 U.K. GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.6 Italy GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.7 Russia GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.8 Nordic Countries GABA Receptor Agonist Drug Market Size, 2017-2028
6.5.9 Benelux GABA Receptor Agonist Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia GABA Receptor Agonist Drug Revenue, 2017-2028
6.6.2 By Region - Asia GABA Receptor Agonist Drug Sales, 2017-2028
6.6.3 China GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.4 Japan GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.5 South Korea GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.6 Southeast Asia GABA Receptor Agonist Drug Market Size, 2017-2028
6.6.7 India GABA Receptor Agonist Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America GABA Receptor Agonist Drug Revenue, 2017-2028
6.7.2 By Country - South America GABA Receptor Agonist Drug Sales, 2017-2028
6.7.3 Brazil GABA Receptor Agonist Drug Market Size, 2017-2028
6.7.4 Argentina GABA Receptor Agonist Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa GABA Receptor Agonist Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa GABA Receptor Agonist Drug Sales, 2017-2028
6.8.3 Turkey GABA Receptor Agonist Drug Market Size, 2017-2028
6.8.4 Israel GABA Receptor Agonist Drug Market Size, 2017-2028
6.8.5 Saudi Arabia GABA Receptor Agonist Drug Market Size, 2017-2028
6.8.6 UAE GABA Receptor Agonist Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Advicenne
7.1.1 Advicenne Corporate Summary
7.1.2 Advicenne Business Overview
7.1.3 Advicenne GABA Receptor Agonist Drug Major Product Offerings
7.1.4 Advicenne GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.1.5 Advicenne Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca GABA Receptor Agonist Drug Major Product Offerings
7.2.4 AstraZeneca GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Athena Drug Delivery Solutions
7.3.1 Athena Drug Delivery Solutions Corporate Summary
7.3.2 Athena Drug Delivery Solutions Business Overview
7.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Major Product Offerings
7.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.3.5 Athena Drug Delivery Solutions Key News
7.4 Biocodex
7.4.1 Biocodex Corporate Summary
7.4.2 Biocodex Business Overview
7.4.3 Biocodex GABA Receptor Agonist Drug Major Product Offerings
7.4.4 Biocodex GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.4.5 Biocodex Key News
7.5 Elan Corporation
7.5.1 Elan Corporation Corporate Summary
7.5.2 Elan Corporation Business Overview
7.5.3 Elan Corporation GABA Receptor Agonist Drug Major Product Offerings
7.5.4 Elan Corporation GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.5.5 Elan Corporation Key News
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Corporate Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Major Product Offerings
7.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.6.5 Eli Lilly and Company Key News
7.7 H.LundBeck, Merck and Co
7.7.1 H.LundBeck, Merck and Co Corporate Summary
7.7.2 H.LundBeck, Merck and Co Business Overview
7.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Major Product Offerings
7.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.7.5 H.LundBeck, Merck and Co Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Major Product Offerings
7.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 NovaDel Pharma
7.9.1 NovaDel Pharma Corporate Summary
7.9.2 NovaDel Pharma Business Overview
7.9.3 NovaDel Pharma GABA Receptor Agonist Drug Major Product Offerings
7.9.4 NovaDel Pharma GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.9.5 NovaDel Pharma Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis GABA Receptor Agonist Drug Major Product Offerings
7.10.4 Novartis GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 OVATION Pharmaceuticals
7.11.1 OVATION Pharmaceuticals Corporate Summary
7.11.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Business Overview
7.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Major Product Offerings
7.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.11.5 OVATION Pharmaceuticals Key News
7.12 Osmotica Pharmaceutical
7.12.1 Osmotica Pharmaceutical Corporate Summary
7.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Business Overview
7.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Major Product Offerings
7.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.12.5 Osmotica Pharmaceutical Key News
7.13 Pfizer
7.13.1 Pfizer Corporate Summary
7.13.2 Pfizer GABA Receptor Agonist Drug Business Overview
7.13.3 Pfizer GABA Receptor Agonist Drug Major Product Offerings
7.13.4 Pfizer GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.13.5 Pfizer Key News
7.14 sanofi-aventis
7.14.1 sanofi-aventis Corporate Summary
7.14.2 sanofi-aventis Business Overview
7.14.3 sanofi-aventis GABA Receptor Agonist Drug Major Product Offerings
7.14.4 sanofi-aventis GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.14.5 sanofi-aventis Key News
7.15 VIVUS
7.15.1 VIVUS Corporate Summary
7.15.2 VIVUS Business Overview
7.15.3 VIVUS GABA Receptor Agonist Drug Major Product Offerings
7.15.4 VIVUS GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.15.5 VIVUS Key News
7.16 XenoPort
7.16.1 XenoPort Corporate Summary
7.16.2 XenoPort Business Overview
7.16.3 XenoPort GABA Receptor Agonist Drug Major Product Offerings
7.16.4 XenoPort GABA Receptor Agonist Drug Sales and Revenue in Global (2017-2022)
7.16.5 XenoPort Key News
8 Global GABA Receptor Agonist Drug Production Capacity, Analysis
8.1 Global GABA Receptor Agonist Drug Production Capacity, 2017-2028
8.2 GABA Receptor Agonist Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global GABA Receptor Agonist Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GABA Receptor Agonist Drug Supply Chain Analysis
10.1 GABA Receptor Agonist Drug Industry Value Chain
10.2 GABA Receptor Agonist Drug Upstream Market
10.3 GABA Receptor Agonist Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 GABA Receptor Agonist Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of GABA Receptor Agonist Drug in Global Market
Table 2. Top GABA Receptor Agonist Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global GABA Receptor Agonist Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global GABA Receptor Agonist Drug Revenue Share by Companies, 2017-2022
Table 5. Global GABA Receptor Agonist Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global GABA Receptor Agonist Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers GABA Receptor Agonist Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers GABA Receptor Agonist Drug Product Type
Table 9. List of Global Tier 1 GABA Receptor Agonist Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GABA Receptor Agonist Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global GABA Receptor Agonist Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global GABA Receptor Agonist Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global GABA Receptor Agonist Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global GABA Receptor Agonist Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global GABA Receptor Agonist Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global GABA Receptor Agonist Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global GABA Receptor Agonist Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global GABA Receptor Agonist Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global GABA Receptor Agonist Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global GABA Receptor Agonist Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global GABA Receptor Agonist Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global GABA Receptor Agonist Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global GABA Receptor Agonist Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global GABA Receptor Agonist Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global GABA Receptor Agonist Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America GABA Receptor Agonist Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America GABA Receptor Agonist Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America GABA Receptor Agonist Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe GABA Receptor Agonist Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe GABA Receptor Agonist Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe GABA Receptor Agonist Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia GABA Receptor Agonist Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia GABA Receptor Agonist Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia GABA Receptor Agonist Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America GABA Receptor Agonist Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America GABA Receptor Agonist Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America GABA Receptor Agonist Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa GABA Receptor Agonist Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa GABA Receptor Agonist Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa GABA Receptor Agonist Drug Sales, (K Pcs), 2023-2028
Table 46. Advicenne Corporate Summary
Table 47. Advicenne GABA Receptor Agonist Drug Product Offerings
Table 48. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca GABA Receptor Agonist Drug Product Offerings
Table 51. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Athena Drug Delivery Solutions Corporate Summary
Table 53. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offerings
Table 54. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Biocodex Corporate Summary
Table 56. Biocodex GABA Receptor Agonist Drug Product Offerings
Table 57. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Elan Corporation Corporate Summary
Table 59. Elan Corporation GABA Receptor Agonist Drug Product Offerings
Table 60. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Eli Lilly and Company Corporate Summary
Table 62. Eli Lilly and Company GABA Receptor Agonist Drug Product Offerings
Table 63. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. H.LundBeck, Merck and Co Corporate Summary
Table 65. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offerings
Table 66. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline GABA Receptor Agonist Drug Product Offerings
Table 69. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. NovaDel Pharma Corporate Summary
Table 71. NovaDel Pharma GABA Receptor Agonist Drug Product Offerings
Table 72. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis GABA Receptor Agonist Drug Product Offerings
Table 75. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. OVATION Pharmaceuticals Corporate Summary
Table 77. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offerings
Table 78. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Osmotica Pharmaceutical Corporate Summary
Table 80. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offerings
Table 81. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Pfizer Corporate Summary
Table 83. Pfizer GABA Receptor Agonist Drug Product Offerings
Table 84. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. sanofi-aventis Corporate Summary
Table 86. sanofi-aventis GABA Receptor Agonist Drug Product Offerings
Table 87. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. VIVUS Corporate Summary
Table 89. VIVUS GABA Receptor Agonist Drug Product Offerings
Table 90. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. XenoPort Corporate Summary
Table 92. XenoPort GABA Receptor Agonist Drug Product Offerings
Table 93. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. GABA Receptor Agonist Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 95. Global GABA Receptor Agonist Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global GABA Receptor Agonist Drug Production by Region, 2017-2022 (K Pcs)
Table 97. Global GABA Receptor Agonist Drug Production by Region, 2023-2028 (K Pcs)
Table 98. GABA Receptor Agonist Drug Market Opportunities & Trends in Global Market
Table 99. GABA Receptor Agonist Drug Market Drivers in Global Market
Table 100. GABA Receptor Agonist Drug Market Restraints in Global Market
Table 101. GABA Receptor Agonist Drug Raw Materials
Table 102. GABA Receptor Agonist Drug Raw Materials Suppliers in Global Market
Table 103. Typical GABA Receptor Agonist Drug Downstream
Table 104. GABA Receptor Agonist Drug Downstream Clients in Global Market
Table 105. GABA Receptor Agonist Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. GABA Receptor Agonist Drug Segment by Type
Figure 2. GABA Receptor Agonist Drug Segment by Application
Figure 3. Global GABA Receptor Agonist Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global GABA Receptor Agonist Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global GABA Receptor Agonist Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. GABA Receptor Agonist Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by GABA Receptor Agonist Drug Revenue in 2021
Figure 9. By Type - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global GABA Receptor Agonist Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global GABA Receptor Agonist Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 19. US GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 24. Germany GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 33. China GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 40. Brazil GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa GABA Receptor Agonist Drug Sales Market Share, 2017-2028
Figure 44. Turkey GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE GABA Receptor Agonist Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global GABA Receptor Agonist Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production GABA Receptor Agonist Drug by Region, 2021 VS 2028
Figure 50. GABA Receptor Agonist Drug Industry Value Chain
Figure 51. Marketing Channels
